PT  - JOURNAL ARTICLE
ED  - , 
TI  - Signaling Brain Tumor Growth
DP  - 2002 Sep 03
TA  - Science's STKE
PG  - tw327--tw327
VI  - 2002
IP  - 148
4099  - http://stke.sciencemag.org/content/2002/148/tw327.short
4100  - http://stke.sciencemag.org/content/2002/148/tw327.full
SO  - Sci. STKE2002 Sep 03; 2002
AB  - Brain tumors are the leading cause of cancer-related deaths in children. The most common of these are medulloblastomas, highly aggressive tumors that arise in the cerebellum and whose molecular etiology is poorly understood. Berman et al. show that initiation and continued growth of these tumors requires the Hedgehog (Hh) cellular signaling pathway. Treatment of mice with cyclopamine, a plant-derived molecule that inhibits Hh signaling, caused regression of medulloblastomas with no apparent side effects; thus, small-molecule antagonists of Hh may merit investigation as a new therapy for human medulloblastoma. D. M. Berman, S. S. Karhadkar, A. R. Hallahan, J. I. Pritchard, C. G. Eberhart, D. N. Watkins, J. K. Chen, M. K. Cooper, J. Taipale, J. M. Olson, P. A. Beachy, Medulloblastoma growth inhibition by Hedgehog pathway blockade, Science 297, 1559-1561 (2002). [Abstract] [Full Text]